Predict enrollment more accurately and increase the number of patients per site using data-driven patient recruitment solutions.
The COVID-19 clinical trials helped the industry get more comfortable with the idea of using decentralized clinical trial (DCT) approaches – including remote patient engagement, connected devices and specialized DCT study team roles – for future clinical trials. They also underscored the need for more intentional patient centricity to keep patients engaged in the trial experience.
This white paper discusses ways to take patient preferences and needs into consideration during the design and delivery of clinical trials, resulting in greater efficiency and patient engagement.
Predict enrollment more accurately and increase the number of patients per site using data-driven patient recruitment solutions.
Technology informed by unparalleled Decentralized Trials (DCT) operational experience and delivered at global scale.
Ease the burden on your sites and make it easier and more appealing for patients to enroll and remain engaged.
Bring trials directly to patients to improve access and engagement, increase quality and shorten timelines.
Combine data science, technology, and analytics driven by artificial intelligence to support new efficiencies and business insights -- without additional capital investment.